Apart from IPF, elevated serum CCL18 levels reflected pulmonary fibrosis activity [21] and correlated with death or the progression of pulmonary disease [15,17,22] in patients with systemic sclerosis (SSc)-associated ILD. Here, CCL18 is linked to pulmonary fibrosis.